News
30 Jun 2026
Ipsen to Acquire Kartos Therapeutics for $450 Million, expanding hemato-oncology late-stage pipeline
French drugmaker Ipsen has agreed to acquire U.S.-based Kartos Therapeutics for $450 million upfront, with the deal potentially rising to…
